Behavioral sensitization following repeated intravenous nicotine administration: Gender differences and gonadal hormones

被引:75
作者
Booze, RM
Welch, MA
Wood, ML
Billings, KA
Apple, SR
Mactutus, CF
机构
[1] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[2] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Biol, Lexington, KY 40536 USA
[4] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
[5] Univ Kentucky, Tobacco & Hlth Res Inst, Lexington, KY 40536 USA
[6] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
tolerance; estrous cyclicity; IV administration; rats;
D O I
10.1016/S0091-3057(99)00169-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Repeated intermittent administration of stimulants is well known to produce behavioral sensitization in male animals. The present studies explored whether 1) behavioral sensitization occurred with the IV route of administration, 2) sensitization was greater in females than in males, 3) sensitization was modulated by gonadectomy, 4) intact adult female rats maintained normal estrous cytology patterns in response to repeated nicotine administration, and 5) the pharmacokinetics of IV nicotine dosing. Adult male, female, castrated, and ovariectomized Sprague-Dawley rats (n = 48) were surgically implanted with an intravenous access port. Animals received 50 mu g/kg IV nicotine once/day for 14 days. Immediately after the initial nicotine injection and the final day 14 nicotine injection, animals were placed in IR photocell activity chambers for 60 min. Observational time sampling of behavior was also simultaneously performed by an observer blind to treatment condition. An increase in behavioral activity of greater than 120% occurred across the 14-day time course of IV nicotine injections. The magnitude of the increase, however, varied as a function of component of activity, gender, and gonadectomy. The behavioral observation data further suggested that the females demonstrated an increased sensitivity to repeated nicotine, as evidenced in a more rapid response, for example, grooming. These behavioral observations were associated with peak arterial levels of nicotine (similar to 25 ng/ml) no greater than the average venous levels of nicotine commonly maintained by cigarette smokers. Repeated IV nicotine, at a dose of 50 mu g/kg, did not interfere with intact female vaginal cytology or body weight; the failure to detect such alterations were not due to inadequate statistical power. Moreover, no nicotine-treated animals displayed persistent vaginal estrous or were acyclic. Collectively, these data suggest that the IV nicotine model may be particularly useful in exploring the gender-dependent effects of nicotine. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:827 / 839
页数:13
相关论文
共 76 条
[1]  
ADIR J, 1976, RES COMMUN CHEM PATH, V13, P173
[2]   RECURRENT HORMONE DEPENDENT CHOREA - EFFECTS OF ESTROGENS AND PROGESTOGENS [J].
BARBER, PV ;
ARNOLD, AG ;
EVANS, G .
CLINICAL ENDOCRINOLOGY, 1976, 5 (03) :291-293
[3]   SMOKING AND THE BEHAVIORAL-EFFECTS OF NICOTINE [J].
BATTIG, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (06) :145-147
[4]   GONADAL-HORMONES AND SEX-DIFFERENCES IN NON-REPRODUCTIVE BEHAVIORS IN RODENTS - ORGANIZATIONAL AND ACTIVATIONAL INFLUENCES [J].
BEATTY, WW .
HORMONES AND BEHAVIOR, 1979, 12 (02) :112-163
[5]   ANALYSIS OF NICOTINE-1'-N-OXIDE IN URINE, IN PRESENCE OF NICOTINE AND COTININE, AND ITS APPLICATION TO STUDY OF IN-VIVO NICOTINE METABOLISM IN MAN [J].
BECKETT, AH ;
GORROD, JW ;
JENNER, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 :S55-&
[6]  
Benowitz N L, 1990, NIDA Res Monogr, V99, P12
[7]  
BENOWITZ NL, 1990, CIBA F SYMP, V152, P186
[8]   CIRCADIAN BLOOD NICOTINE CONCENTRATIONS DURING CIGARETTE-SMOKING [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :758-764
[9]   STABLE ISOTOPE STUDIES OF NICOTINE KINETICS AND BIOAVAILABILITY [J].
BENOWITZ, NL ;
JACOB, P ;
DENARO, C ;
JENKINS, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) :270-277
[10]  
BENOWITZ NL, 1984, CLIN PHARMACOL THER, V234, P153